KR20010042104A - 모발 손실을 늦추기 위한 레틴산 활성 억제제의 용도 - Google Patents

모발 손실을 늦추기 위한 레틴산 활성 억제제의 용도 Download PDF

Info

Publication number
KR20010042104A
KR20010042104A KR1020007010470A KR20007010470A KR20010042104A KR 20010042104 A KR20010042104 A KR 20010042104A KR 1020007010470 A KR1020007010470 A KR 1020007010470A KR 20007010470 A KR20007010470 A KR 20007010470A KR 20010042104 A KR20010042104 A KR 20010042104A
Authority
KR
South Korea
Prior art keywords
hair
benzoic acid
acid
retinic
activity inhibitor
Prior art date
Application number
KR1020007010470A
Other languages
English (en)
Korean (ko)
Inventor
두뜨르메삐치쟝-다니엘
마르꼬네꺄롤
Original Assignee
갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨. filed Critical 갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨.
Publication of KR20010042104A publication Critical patent/KR20010042104A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020007010470A 1998-03-31 1999-03-24 모발 손실을 늦추기 위한 레틴산 활성 억제제의 용도 KR20010042104A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR98/03978 1998-03-31
FR9803978A FR2776511B1 (fr) 1998-03-31 1998-03-31 Utilisation dans ou pour la preparation d'une composition d'au moins un inhibiteur de l'activite de l'acide retinoique
PCT/FR1999/000687 WO1999049838A1 (fr) 1998-03-31 1999-03-24 Utilisation des inhibiteurs de l'activite de l'acide retinoique pour retarder la chute des cheveux

Publications (1)

Publication Number Publication Date
KR20010042104A true KR20010042104A (ko) 2001-05-25

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007010470A KR20010042104A (ko) 1998-03-31 1999-03-24 모발 손실을 늦추기 위한 레틴산 활성 억제제의 용도

Country Status (16)

Country Link
EP (1) EP1066017A1 (ja)
JP (1) JP2002509870A (ja)
KR (1) KR20010042104A (ja)
CN (1) CN1298290A (ja)
AR (1) AR015551A1 (ja)
AU (1) AU2938899A (ja)
BR (1) BR9908411A (ja)
CA (1) CA2324899A1 (ja)
FR (1) FR2776511B1 (ja)
HU (1) HUP0102411A3 (ja)
IL (1) IL137859A0 (ja)
NO (1) NO20004880L (ja)
PL (1) PL343004A1 (ja)
RU (1) RU2193877C2 (ja)
WO (1) WO1999049838A1 (ja)
ZA (1) ZA200004483B (ja)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
FR2739777B1 (fr) * 1995-10-11 1997-11-14 Cird Galderma Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
CN1255396C (zh) * 1996-03-18 2006-05-10 卫材株式会社 含有稠环的羧酸衍生物

Also Published As

Publication number Publication date
HUP0102411A2 (hu) 2001-11-28
CN1298290A (zh) 2001-06-06
JP2002509870A (ja) 2002-04-02
BR9908411A (pt) 2000-12-05
CA2324899A1 (fr) 1999-10-07
PL343004A1 (en) 2001-07-30
NO20004880L (no) 2000-11-30
AR015551A1 (es) 2001-05-02
ZA200004483B (en) 2002-02-27
AU2938899A (en) 1999-10-18
HUP0102411A3 (en) 2002-12-28
IL137859A0 (en) 2001-10-31
RU2193877C2 (ru) 2002-12-10
WO1999049838A1 (fr) 1999-10-07
EP1066017A1 (fr) 2001-01-10
FR2776511B1 (fr) 2001-05-11
FR2776511A1 (fr) 1999-10-01
NO20004880D0 (no) 2000-09-28

Similar Documents

Publication Publication Date Title
US20020044953A1 (en) Use of non-prostanoic agonists of prostaglandin EP-2 and/or EP-4 receptors as cosmetic agents for attenuating, reducing or stopping the loss of head hair and other hairs
US7351404B2 (en) Method of enhancing hair growth
ES2198662T3 (es) Uso de retinoides como agente inductor de la pigmentacion de la piel.
US6955816B2 (en) Anti-aging skin care composition and uses thereof
AU610632B2 (en) Improvements in or relating to methods of treating damaged skin
US5739111A (en) Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone
US20050123577A1 (en) Use of prostaglandin EP-3 receptor antagonists as cosmetic agents for attenuating, reducing or stopping the loss of head hair and other hairs
US5514672A (en) Use of retinoids and compositions containing same for hair growth
RU2316325C2 (ru) Гетероциклическое соединение, стимулирующее или вызывающее рост волос или ресниц и/или препятствующее их выпадению, композиция, содержащая соединение, ее применение
US6001812A (en) Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone
JPH07238007A (ja) 毛髪の脱落防止および新毛髪成長刺激方法
JP2006517909A (ja) スチリル−ピラゾール化合物を含有する毛髪のトリートメントのための組成物、及び毛髪又は睫毛の成長を刺激又は誘発させ、及び／又は抜毛を停止するための該組成物の使用
KR20010043147A (ko) 멜라닌 생성을 촉진하는 화합물의 확인을 위한 분석법 및그 분석법에 의해 확인되는 레티노이드류 화합물
US5962508A (en) Retinoid receptor agonists for promoting hair growth and/or retarding hair loss
KR101792402B1 (ko) 니코틴산 아데닌 디뉴클레오티드 인산 및 그 유도체를 포함하는 발모 또는 육모 촉진제
US5827500A (en) Process for identifying RAR-receptor-antagonist compounds
KR20010042104A (ko) 모발 손실을 늦추기 위한 레틴산 활성 억제제의 용도
CA2612235C (en) Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefor
MXPA00008971A (en) Use of retinoic acid activity inhibitors to slow down hair loss
DK2695611T3 (en) Eprotirome for use in the prevention and / or treatment of hair disorders and their compositions
JP2007008936A (ja) ケラチン繊維の成長を刺激若しくは誘導するため、及び／またはケラチン繊維の損失を減少するため、及び／またはケラチン繊維の密度を増大するためのベンジリデン−１，３−チアゾリジン−２，４−ジオン化合物、その使用、及び組成物
JP2007008938A (ja) ケラチン繊維の成長を刺激若しくは誘導するため、及び／またはケラチン繊維の損失を減少するためのベンジル−１，３−チアゾリジン−２，４−ジオン化合物、その使用、及び組成物
JP2001302494A (ja) スキンケア用のレチノイドおよびカフェインを含有する組成物
JP2008174556A (ja) レチノイドとクロメノン誘導体とを含有する組成物
JPH0232007A (ja) 養毛剤

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application